(Q34536009)

2 August 2017

1 reference

title

Antidepressant-induced hepatotoxicity. (English)

1 reference

2 August 2017

1 reference

M Isabel Lucena

1

1 reference

2 August 2017

Alfonso Carvajal

series ordinal

2

1 reference

2 August 2017

Raúl J Andrade

series ordinal

3

1 reference

2 August 2017

Alfonso Velasco

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

Expert Opinion on Drug Safety

2 August 2017

1 reference

2 August 2017

2

1 reference

2 August 2017

3

1 reference

2 August 2017

249-262

1 reference

Clinical practice. Adolescent depression

2 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Treatment of depression following acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Pharmacology of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Screening for depression: recommendations and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Hepatotoxicity of psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Criteria of drug-induced liver disorders. Report of an international consensus meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Isoniazid and Iproniazid: Activation of Metabolites to Toxic Intermediates in Man and Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Phenelzine-induced fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Intrahepatic cholestasis associated with moclobemide leading to death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Hepatic failure associated with imipramine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Lethal hepatic necrosis after therapy with imipramine and desipramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Acute Hepatic Necrosis Following Treatment with Amitriptyline and Diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Amitriptyline-induced fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Nortriptyline-induced hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Doxepin-induced recurrent acute hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Genetic predisposition to drug hepatotoxicity: role in hepatitis caused by amineptine, a tricyclic antidepressant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Toxicity of tricyclic antidepressants to isolated rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Acute hepatitis due to fluoxetine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Severe hepatotoxicity with jaundice associated with paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Paroxetine and hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Hepatic injury caused by mianserin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Acute hepatitis induced by bupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Acute cholestatic hepatitis induced by bupropion prescribed as pharmacological support to stop smoking. A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Trazodone and intrahepatic cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Fatal hepatic necrosis associated with trazodone and neuroleptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Venlafaxine-associated hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

A review of the common properties of drugs with idiosyncratic hepatotoxicity and the "multiple determinant hypothesis" for the manifestation of idiosyncratic drug toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Clotiazepam-induced acute hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Bentazepam-associated chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

The rational use of potentially hepatotoxic medications in patients with underlying liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Tolerance after liver transplantation: does it exist and can immunosuppression be withdrawn?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Paroxetine for the prevention of depression induced by interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Acute fulminant hepatitis after treatment with rabeprazole and terbinafine: is rabeprazole the culprit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Acute liver injury associated with the use of ebrotidine, a new H2-receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.3.249

21 January 2018

Identifiers

DOI

10.1517/14740338.2.3.249

1 reference

release_3eue5sd72jcy3ce6kheh3k7q3y

2 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3eue5sd72jcy3ce6kheh3k7q3y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference